SVB Securities Keeps Their Buy Rating on Jazz Pharmaceuticals (JAZZ)
In a report released on June 4, Marc Goodman from SVB Securities maintained a Buy rating on Jazz Pharmaceuticals (JAZZ – Research Report)....
Source: businessinsider.com
Larkin Finbar News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Larkin Finbar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Larkin Finbar Today - Breaking & Trending Today
RBC Capital Reaffirms Their Buy Rating on Jazz Pharmaceuticals (JAZZ)
RBC Capital analyst Gregory Renza maintained a Buy rating on Jazz Pharmaceuticals (JAZZ – Research Report) on April 6 and set a price targ...
Source: businessinsider.com
Bank of America Securities Keeps Their Buy Rating on Jazz Pharmaceuticals (JAZZ)
Bank of America Securities analyst Jason Gerberry reiterated a Buy rating on Jazz Pharmaceuticals (JAZZ – Research Report) today and set a...
Source: businessinsider.com